- Display 15 Products per page
Published: February 1, 2010 | Price: $1,500.00 – $8,400.00
The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical companies are working on new prophylactics, some of which may see near-term marketing. What illnesses may see a vaccine option in the coming years? Which vaccines will have the most successful business model? Who are the major companies in this market, and possible new entrants? What can current vaccine success stories tell us about the future of the vaccine...Published: March 1, 2010 | Price: $1,500.00 – $3,000.00
The medical device market is vast and everything from a large imaging system to a disposable item can be classified as a type of medical device. Throughout the past decade, Kalorama has covered many device markets in detail. Certain areas such as infusion pumps, patient monitoring and catheters have shown promising growth. Others have solid market leaders earning stable revenue. What are the best markets for medical devices? Who are the main participants and what have been their recent competitive...Published: September 1, 2010 | Price: $1,500.00 – $3,000.00
Kalorama has been researching and examining the development of cancer vaccines for seven years. In April 2010, the cancer vaccine market experienced one of the biggest achievements in the therapeutic vaccine treatment of cancer—the approval of the prostate cancer vaccine PROVENGE (TM). This, in addition to the success of cervical cancer vaccine products, has created a viable market for what was merely a speculative area just one decade ago. Even with achievements for some companies, numerous vaccines with apparently strong...Published: November 1, 2010 | Price: $1,500.00 – $5,000.00
In the U.S. an estimated 18 million people receive some kind of home health care from either professional or unpaid caregivers, and most of these individuals require home care products. This demand has not escaped the notice of makers of wheelchairs, home therapy products, monitors, and other devices, many of which are available on an over-the-counter basis, although some require prescriptions. This Kalorama Information report The Market for Home Care Products, 6th Edition represents the sixth time that Kalorama Information...Published: March 1, 2011 | Price: $1,500.00 – $2,500.00
This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows customers to save almost $4,500 off the cost of the individual reports. THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTIC TESTS, 7th Edition This 900 page report contains coverage of all segments of In Vitro...Published: May 2, 2012 | Price: $1,500.00 – $3,000.00
Medical device makers faced a productive but challenging year in 2011. They innovated existing lines, launched new devices and invested in R&D. But they also experienced funding cutbacks and new taxes and regulations. In this report, The Global Market for Medical Devices, 3rd. Edition, Kalorama Information analyzes the current device market in the United States, Europe, Asia and globally, profiles the key players and discusses trends important for market watchers to know. The medical device market is vast -- everything...Published: September 19, 2012 | Price: $1,500.00 – $3,000.00
This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC infection, heart attach, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc.; vaccines that address these and other not-yet-vaccine-preventable conditions are...Published: May 20, 2013 | Price: $1,500.00 – $2,250.00
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and as a result, the range of therapeutic options available to physicians and other clinicians has expanded. Solutions to pain disorders are still elusive but continued human and animal studies will help to further identify the biochemical and neurophysiological factors that influence pain. The future of pain...Published: June 18, 2013 | Price: $1,500.00 – $3,000.00
This report, Out of Pocket Healthcare 2013, is Kalorama's latest estimates for the amount spent by consumers on their own (through cash payments, credit cards, FSAs and finance programs) for healthcare services. The out-of -pocket market for the following areas are included: Doctors Pharmaceuticals Hospitals ER Vision Dental Elective Procedures The report estimates the amount spent in cash/checks and the amount financed. As part of the report, spending for the following healthcare costs are provided for years 2008-2016: Premiums Co...Published: June 25, 2013 | Price: $1,500.00 – $3,000.00
The growing demands on the health industry have resulted in higher demand for new and better medical technology products. New technologies in the health IT segment are emerging in response to increased healthcare needs of an aging population, streamlining and efficiency demands, changes in reimbursement, new wireless technologies including wireless monitoring technologies, decreasing healthcare resources, an emphasis on reducing hospital days, and proven cost-effectiveness. In particular, the Tablet PC has been focused on as it mimics clipboards and other products...Published: July 1, 2013 | Price: $1,500.00 – $3,000.00
Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends) Next-generation sequencing is discussed frequently as a key to clinical diagnostics in the future. This report looks at the status of NGS today, and seeks to provide insights on the “on-the-ground” status of clinical sequencing. In the course of doing this, the report seeks to answer the following questions: What is the status of clinical applications for Next Gen in laboratories currently? What...Published: September 13, 2013 | Price: $1,500.00 – $3,000.00
Brazil is the fifth largest country in the world, after Russia, Canada, China and the United States. The size of the country as made it a focus for IVD companies. This report, The IVD Market in Brazil, provides market estimates and forecasts for the main categories of in vitro diagnostics, and forecasts those markets to 2017. Information was obtained by both primary and secondary sources. Annual reports, trade publications, as well as telephone and email surveys of IVD manufacturers operating...Published: March 21, 2018 | Price: $1,500.00 – $3,000.00
This report provides market estimates and forecasts for point-of-care glucose testing. Information in this report is from the latest published figures for companies participating in the market as well as recent interviews. The following markets analysis is provided in this report: Global POC Glucose Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level) POC Blood Glucose Testing Regional Market Analysis, 2017 (US, Europe, Asia, ROW) Global POC Glucose Self-Testing Market (includes continuous glucose devices) ...Published: March 28, 2018 | Price: $1,500.00 – $3,000.00
Convenience clinics are designed to occupy small spaces and provide just basic care. Therefore, they do not use most of the sophisticated medical equipment found in hospitals or specialty centers such as advanced imaging devices. In fact, while a few larger centers have x-ray machines, most do not. However, retail clinics are becoming relatively large users of point-of-care (POC) tests, clinical chemistry and immunoassay laboratory tests and vaccines. This chapter examines the effect of retail clinics on each of these...Published: October 25, 2018 | Price: $1,500.00 – $3,000.00
This brief report contains Kalorama Information's estimates of European in vitro diagnostics markets including current (2018) country level estimates and forecasts. Content for this report is based on information in The Worldwide Market for In Vitro Diagnostic Tests, 11th Edition, with additional forecasting information.